2025年4月9日，歐盟食品安全局（EFSA）發(fā)布消息，歐盟食品安全局（EFSA）發(fā)布關(guān)于鹽酸硫胺（thiamine hydrochloride）和硝酸硫胺（thiamine mononitrate）作為所有動(dòng)物飼料添加劑的授權(quán)更新申請(qǐng)的評(píng)估。
經(jīng)過(guò)評(píng)估，專家小組得出結(jié)論，該添加劑在授權(quán)使用條件下對(duì)目標(biāo)物種、消費(fèi)者和環(huán)境都是安全的。在授權(quán)更新的情況下，無(wú)需評(píng)估添加劑的功效。部分原文報(bào)道如下：
Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the safety and efficacy of vitamin B1 (thiamine hydrochloride and thiamine mononitrate) for the renewal of its authorisation as nutritional feed additive for all animal species. The Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) concluded that vitamin B1 remains safe for all animal species, consumers and the environment. Thiamine mononitrate is not irritant to the eyes, while hydrochloride is not irritant to skin, but it is irritant to the eyes. Both salts of thiamine are considered skin and respiratory sensitisers, and any exposure is considered a risk. These conclusions would apply, in principle, to any preparations produced with the thiamine mononitrate. The Panel concluded there is no need for assessing the efficacy of the additive in the context of the renewal of the authorisation.
經(jīng)過(guò)評(píng)估，專家小組得出結(jié)論，該添加劑在授權(quán)使用條件下對(duì)目標(biāo)物種、消費(fèi)者和環(huán)境都是安全的。在授權(quán)更新的情況下，無(wú)需評(píng)估添加劑的功效。部分原文報(bào)道如下：
Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the safety and efficacy of vitamin B1 (thiamine hydrochloride and thiamine mononitrate) for the renewal of its authorisation as nutritional feed additive for all animal species. The Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) concluded that vitamin B1 remains safe for all animal species, consumers and the environment. Thiamine mononitrate is not irritant to the eyes, while hydrochloride is not irritant to skin, but it is irritant to the eyes. Both salts of thiamine are considered skin and respiratory sensitisers, and any exposure is considered a risk. These conclusions would apply, in principle, to any preparations produced with the thiamine mononitrate. The Panel concluded there is no need for assessing the efficacy of the additive in the context of the renewal of the authorisation.
